- Home
- AVIR vs NMG Comparison
AVIR vs NMG Comparison
Compare AVIR & NMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- NMG
- Stock Information
- Founded
- AVIR 2012
- NMG 2011
- Country
- AVIR United States
- NMG Canada
- Employees
- AVIR N/A
- NMG N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- NMG Other Metals and Minerals
- Sector
- AVIR Health Care
- NMG Basic Materials
- Exchange
- AVIR Nasdaq
- NMG Nasdaq
- Market Cap
- AVIR 273.7M
- NMG 245.1M
- IPO Year
- AVIR 2020
- NMG 2017
- Fundamental
- Price
- AVIR $2.55
- NMG $1.96
- Analyst Decision
- AVIR Hold
- NMG Strong Buy
- Analyst Count
- AVIR 1
- NMG 2
- Target Price
- AVIR $6.00
- NMG $2.58
- AVG Volume (30 Days)
- AVIR 532.5K
- NMG 92.3K
- Earning Date
- AVIR 05-12-2025
- NMG 05-23-2025
- Dividend Yield
- AVIR N/A
- NMG N/A
- EPS Growth
- AVIR N/A
- NMG N/A
- EPS
- AVIR N/A
- NMG N/A
- Revenue
- AVIR N/A
- NMG N/A
- Revenue This Year
- AVIR N/A
- NMG N/A
- Revenue Next Year
- AVIR N/A
- NMG N/A
- P/E Ratio
- AVIR N/A
- NMG N/A
- Revenue Growth
- AVIR N/A
- NMG N/A
- 52 Week Low
- AVIR $2.60
- NMG $1.22
- 52 Week High
- AVIR $4.15
- NMG $2.58
- Technical
- Relative Strength Index (RSI)
- AVIR 37.12
- NMG 61.15
- Support Level
- AVIR $2.66
- NMG $1.58
- Resistance Level
- AVIR $3.01
- NMG $1.72
- Average True Range (ATR)
- AVIR 0.15
- NMG 0.12
- MACD
- AVIR -0.03
- NMG 0.02
- Stochastic Oscillator
- AVIR 7.02
- NMG 82.30
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About NMG Nouveau Monde Graphite Inc.
Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The company currently operates in two segments: the Matawinie Mine Project and the Battery Material Plant project.